This Clinical Pharmacy Specialist position will be responsible for the provision and oversight of pharmacotherapy for adult multiple myeloma, blood and marrow transplant (BMT), and lymphoma patients in both the acute care setting and the Inpatient Outpatient (IPOP) Clinic. Our unique IPOP Clinic, located adjacent to the inpatient units, allows for patients undergoing BMT or treatment for hematologic malignancies to receive safe, quality, and cost-effective outpatient care, while minimizing the need for hospitalization. Continuity of care is provided for patients throughout the transplant and treatment processes, including non-myeloablative and myeloablative hematopoietic stem cell transplant conditioning regimens, chemotherapy, immunotherapy, stem cell infusions, and donor lymphocyte infusions.
With a team of two other MTL Clinical Pharmacy Specialists, this position will rotate through both the inpatient unit and IPOP Clinic. Responsibilities include: participation in daily patient care rounds with a multidisciplinary team; assisting with discharge coordination, managing questions and clinical issues related to patients receiving chemotherapy, immunotherapy, and hematopoietic stem cell transplant; providing patient education with a focus on antimicrobials and immunosuppression; participating in antimicrobial stewardship activities; and coordinating care transitions between the IPOP Clinic and inpatient MTL and hematologic malignancy care teams.
The MTL Clinical Pharmacy Specialist will also provide education to students, residents, pharmacists, and other health care practitioners and serve as a preceptor for pharmacy residents of ASHP-accredited PGY1 Pharmacy Practice and PGY2 specialty practice programs. Faculty appointments are available through affiliations with the University of Maryland School of Pharmacy and the Johns Hopkins University School of Medicine. Additionally, the successful candidate will support research conducted by the institution and assume a leadership role within the Department of Pharmacy.
Preferred qualifications for this position include the completion of a PharmD degree, PGY1 residency, and PGY2 specialty residency in oncology with experience in blood and marrow transplant. Board of Pharmacy Specialties (BPS) certification is required within two years of start date.
Anand Khandoobhai, PharmD, MS Division Director, Weinberg Oncology Pharmacy The Johns Hopkins Hospital – Department of Pharmacy 600 North Wolfe Street – Carnegie 180 Baltimore, MD 21287 email@example.com
Internal Number: Onc MTL
About Johns Hopkins Hospital
From the 1889 opening of The Johns Hopkins Hospital, to the opening of the School of Medicine four years later, there emerged the concept of combining research, teaching and patient care. This model, the first of its kind, would lead to a national and international reputation for excellence and discovery.Today, Johns Hopkins uses one overarching name—Johns Hopkins Medicine—to identify its entire medical enterprise. This $6.7 billion system unites the physicians and scientists of the Johns Hopkins University School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System.